-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, OPc5gvUBo+BS0Jil18Tpil8bZ4ATHZfmQbABShlVUUygI6RjLOmufZP1G4EguSs+ XATAfymZoXC5e3feuf+IYA== 0001019687-03-000491.txt : 20030313 0001019687-03-000491.hdr.sgml : 20030313 20030313130819 ACCESSION NUMBER: 0001019687-03-000491 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20030313 ITEM INFORMATION: Other events ITEM INFORMATION: Financial statements and exhibits FILED AS OF DATE: 20030313 FILER: COMPANY DATA: COMPANY CONFORMED NAME: SIMULATIONS PLUS INC CENTRAL INDEX KEY: 0001023459 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMPUTER INTEGRATED SYSTEMS DESIGN [7373] IRS NUMBER: 954595609 FISCAL YEAR END: 0831 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 333-05600-LA FILM NUMBER: 03602034 BUSINESS ADDRESS: STREET 1: 1220 W. AVENUE J STREET 2: * CITY: LANCASTER STATE: CA ZIP: 93534-2902 BUSINESS PHONE: 661-723-7723 MAIL ADDRESS: STREET 1: 1220 W. AVENUE J STREET 2: * CITY: LANCASTER STATE: CA ZIP: 93534-2902 8-K 1 simulations_8k-031303.txt UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 March 13, 2003 ----------------- (Date of the earliest event reported) Simulations Plus, Inc. ---------------------- (Exact name of registrant as specified in its charter) California 000-21665 95-4595609 ---------- ------------ ---------- (State or other jurisdiction (Commission (I.R.S. Employer of incorporation) File Number) Identification No.) 1220 W. Avenue J, Lancaster, California 93534 --------------------------------------------- (Address of principal executive offices) (Zip Code) 661-723-7723 ------------- Registrant's telephone number, including area code ITEM 5: OTHER EVENTS. On March 11, 2003, Simulations Plus, Inc. (the "Company") issued a press release announcing preliminary revenue for the fiscal quarter ending February 28, 2003. A copy of the press release is attached hereto as Exhibit 99.1. This report on Form 8-K (the "Report"), including the disclosures set forth herein, contains certain forward-looking statements that involve substantial risks and uncertainties. When used herein, the terms "anticipates," "expects," "estimates," "believes" and similar expressions, as they relate to us or our management, are intended to identify such forward-looking statements. Forward-looking statements in this Report or hereafter, including in other publicly available documents filed with the Securities and Exchange Commission (the "Commission"), reports to the stockholders of Simulations Plus, Inc., a California corporation (the "Company" or "us," "our" or "we") and other publicly available statements issued or released by us involve known and unknown risks, uncertainties and other factors which could cause our actual results, performance (financial or operating) or achievements to differ from the future results, performance (financial or operating) or achievements expressed or implied by such forward-looking statements. Such future results are based upon management's best estimates based upon current conditions and the most recent results of operations. These risks include, but are not limited to, the risks set forth herein and in such other documents filed with the Commission, each of which could adversely affect our business and the accuracy of the forward-looking statements contained herein. Our actual results, performance or achievements may differ materially from those expressed or implied by such forward-looking statements. ITEM 7: FINANCIAL STATEMENTS, PRO FORMA FINANCIAL INFORMATION AND EXHIBITS. ------------------------------------------------------------------ (c) Exhibits 99.1 Press Release dated March 11, 2003. SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. SIMULATIONS PLUS, INC. Dated: March 13, 2003 By: /s/ Walter S. Woltosz ------------------------------------- Walter S. Woltosz Chief Executive Officer and President EX-99.1 3 simulations_8kex99-1.txt EXHIBIT 99.1 SIMULATIONS PLUS REPORTS PRELIMINARY SECOND QUARTER FISCAL 2003 REVENUE COMPANY SETS NEW REVENUE RECORDS FOR SECOND QUARTER AND SIX MONTHS LANCASTER, CA, MARCH 11, 2003. Simulations Plus, Inc. (OTCBB: SIMU.OB), the leading provider of ADME absorption simulation and neural net structure-to-property prediction software for pharmaceutical discovery and development, today reported preliminary revenue for the fiscal second quarter and six months ended February 28, 2003. Momoko Beran, chief financial officer of Simulations Plus, said, "We expect to report record total revenues for the fiscal second quarter and six months ended February 28, 2003. Pharmaceutical software and services revenues increased 4.2% to $572,000 for the second quarter compared to $549,000 for the second fiscal quarter of 2002 and for the first six months increased 19.9% to $1,121,000, compared to $935,000 for the same period in fiscal 2002. Total revenues increased 1.1% to $1,119,000 for the second quarter compared to $1,107,000 for the second fiscal quarter of 2002. Second quarter revenues for the Words+ subsidiary decreased 2.8% over last year's second quarter and, for the first six months ending February 28, Words+ revenues decreased 5.3%. Total revenues for the first six months, including the Words+ subsidiary, increased 3.9% to $2,196,000, compared to $2,114,000 for the same period in fiscal 2002." Walt Woltosz, chairman and chief executive officer of Simulations Plus, commented, "Our steady growth trend continues despite the soft economic conditions worldwide. Our pharmaceutical software products are referenced more and more by scientists at the many important scientific meetings held around the world. At a recent Molecular Biopharmaceutics meeting in January, there were six scientific poster presentations from scientists in industry and academia that utilized GastroPlus(TM) to perform their studies while our competition was noticeably absent." Woltosz continued, "Our forthcoming QMPRchitect(TM) product, designed to enable scientists to easily build predictive models from their own experimental data, is receiving very strong interest. QMPRchitect users will also want QMPRPlus(TM), because they work hand-in-hand. Therefore, we expect QMPRchitect to provide a boost in QMPRPlus licenses as well. We plan to release QMPRchitect during the third quarter, thereby increasing our number of core products from two to three, and we expect this product to contribute to additional growth in revenues and earnings." ABOUT SIMULATIONS PLUS, INC. Simulations Plus, Inc., is a premier developer of groundbreaking drug discovery and development simulation software, which is licensed to and used in the conduct of drug research by major pharmaceutical and biotechnology companies worldwide. The Company has two other businesses, Words+, Inc. and FutureLab(TM), which are based on its proprietary software technologies. Simulations Plus, Inc., is headquartered in Southern California and trades on the OTCBB under the symbol "SIMU.OB." For more information, visit our Web site at www.simulations-plus.com. Safe Harbor Statement Under the Private Securities Litigation Act 1995 - With the exception of historical information, the matters discussed in this press release are forward-looking statements that involve a number of risks and uncertainties. The actual future results of the Company could differ significantly from those statements. Factors that could cause or contribute to such differences include, but are not limited to: the ability of the company to maintain its competitive advantage, the general economics of the pharmaceutical industry, the ability of the company to attract and maintain sufficient scientific and technical staff to sustain its R&D and customer support functions, the ability of the company to finance growth, the acceptance of QMPRchitect by the industry, and a sustainable market. Further information on the Company's risk factors is contained in the Company's quarterly and annual reports as filed with the Securities and Exchange Commission. ### -----END PRIVACY-ENHANCED MESSAGE-----